The U.S. Food and Drug Administration (FDA) is approving Pfizer’s vaccine to vaccinate children and adolescents against the coronavirus epidemic. The New York Times, citing FDA officials, said the vaccine for 12-15 year old’s could be approved this week.
The FDA approved Pfizer vaccines for people 16 and older in December last year. If approved for vaccination, another 13 million people in the United States would be eligible for the vaccine.
If approved by the FDA, the US Centers for Disease Control and Prevention (CDC) will examine the results of Pfizer vaccine trials on teenagers. If the company gives clearance after the examination, the application of vaccine will start among the children and adolescents.
In the meantime, Pfizer claims that it has tested the vaccine on 2,260 volunteers. They have claimed that the effectiveness of the vaccine is 100 percent.